SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-104425
Filing Date
2023-04-18
Accepted
2023-04-18 10:24:01
Documents
14
Period of Report
2023-04-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d483909d8k.htm   iXBRL 8-K 26171
2 EX-99.1 d483909dex991.htm EX-99.1 21651
6 GRAPHIC g483909dsp5.jpg GRAPHIC 5455
  Complete submission text file 0001193125-23-104425.txt   184445

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rptx-20230418.xsd EX-101.SCH 2511
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20230418_lab.xml EX-101.LAB 17955
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20230418_pre.xml EX-101.PRE 11223
8 EXTRACTED XBRL INSTANCE DOCUMENT d483909d8k_htm.xml XML 3512
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 23825782
SIC: 2834 Pharmaceutical Preparations